Results 181 to 190 of about 79,480 (272)

A Case Report of Left Pyelonephritis With Low‐Grade Contralateral Vesicoureteral Reflux After Robot‐Assisted Right Nephroureterectomy

IJU Case Reports, Volume 9, Issue 5, September 2026.
ABSTRACT Introduction Pyelonephritis with contralateral vesicoureteral reflux (VUR) after robot‐assisted radical nephroureterectomy (RANU) in a solitary kidney has rarely been reported. Case Presentation A 73‐year‐old woman with preoperative lower urinary tract symptoms (LUTS; IPSS 15, OABSS 7) underwent right RANU for urothelial carcinoma of the renal
Shuhei Kusano, Shohei Tobu, Minika Yukimoto, Kyohei Matsushita, Akihiro Maeda, Yuka Kakinoki, Hiroaki Kakinoki, Maki Kawasaki, Mitsuru Noguchi   +8 more
wiley   +1 more source

Remarkable Response to Immune Checkpoint Inhibition After Early Aggressive Recurrence Following Robot‐Assisted Radical Cystectomy for Bladder Squamous Cell Carcinoma: A Case Report

IJU Case Reports, Volume 9, Issue 5, September 2026.
ABSTRACT Introduction Squamous cell carcinoma is a rare bladder cancer subtype with poor prognosis in advanced stages. Currently, there is no established systemic therapy, including immune checkpoint inhibitors, for this subtype. Case Presentation A 49‐year‐old man with pure bladder squamous cell carcinoma arising from a diverticulum with pelvic lymph ...
Kazuma Soya, Takeru Fujimoto, Yu Osaki, Koji Matsumoto, Yusuke Takei, Yoshio Sugino, Tsutomu Maruta, Hiroshi Iwamura   +7 more
wiley   +1 more source

Perioperative and Oncological Outcomes of Robot-assisted <i>Versus</i> Open Radical Cystectomy: A Propensity Score-matched Multicenter Study from Japan. [PDF]

In Vivo
Yamashita S, Yasuhara M, Higuchi M, Iwagami S, Wakamiya T, Matsumura N, Nishihata M, Kohjimoto Y.   +7 more
europepmc   +1 more source

Definitive Histologic Diagnosis of Bone Marrow Carcinomatosis Followed by Dose‐Adjusted Chemotherapy in Metastatic Urothelial Carcinoma: A Case Report

IJU Case Reports, Volume 9, Issue 5, September 2026.
ABSTRACT Introduction Bone marrow carcinomatosis (BMC) is a rare manifestation of metastatic urothelial carcinoma (UC) that may mimic hematologic disease and cause severe cytopenia, diagnostic difficulty, and rapid clinical deterioration. Case Presentation A 65‐year‐old man presented with back pain, thrombocytopenia, and leukoerythroblastosis.
Shohei Yamaki, Yuki Endo, Jun Akatsuka, Hikaru Mikami, Shunsuke Ikuma, Kotaro Obayashi, Masato Yanagi, Yuka Toyama, Go Kimura, Yukihiro Kondo   +9 more
wiley   +1 more source

Past, Present, and Future of Telerobotic Surgery in Urology: From Technological Breakthroughs to Global Adoption

iNew Medicine, Volume 2, Issue 3, September 2026.
The Development and Future of Remote Robots in Urology. ABSTRACT Ever since the “Lindbergh Operation” in 2001, the field of remote robotic surgery has transformed from theoretical study toward practical clinical integration on a global scale. Considering the millimeter‐level precision that is required in the field of urological oncology, remote ...
Cheng Yang, Jialong Zhang, Hao Li, Jun Zhou, Tai Sheng, Xu Zhang, Chaozhao Liang   +6 more
wiley   +1 more source

BCG after trimodality therapy: managing non-muscle-invasive recurrence in the irradiated bladder. [PDF]

Front Oncol
Fazaa N, Eigner E, Atallah M, Shafran Y, Amiel G, Hoffman A.   +5 more
europepmc   +1 more source

Population Pharmacokinetics and Exposure–Response of Sasanlimab, a Checkpoint Inhibitor, in Patients with Non‐Muscle Invasive Bladder Cancer and Other Solid Tumors

The Journal of Clinical Pharmacology, Volume 66, Issue 9, September 2026.
Abstract Sasanlimab is a monoclonal antibody (mAb) which blocks human programed cell death protein 1. It is administered subcutaneously (SC), currently under development for non‐muscle invasive bladder cancer (NMIBC) with a recommended flat dose of 300 mg every 4 weeks (Q4W).
Joanna C. Masters, Brian Jermain, Alan Liu, Rossano Cesari, Anna Maria Calella, Elisabete Michelon, Caimiao Wei, Susana Liu, Joseph Piscitelli   +8 more
wiley   +1 more source

CircFut8 Suppresses Bladder Cancer by Modulating SRSF9‐Dependent Pre‐mRNA Splicing

The Journal of Gene Medicine, Volume 28, Issue 9, September 2026.
This schematic illustrates the mechanism by which circFut8 suppresses bladder cancer progression. Under high circFut8 levels, circFut8 competitively binds the splicing factor SRSF9, reducing SRSF9's association with FUT8 pre‐mRNA. This promotes exon 3 skipping, leading to increased production of the FUT8‐4 splice variant, which correlates with reduced ...
Weifeng Yang, Lv Yao, Lijun Wan, Changshui Zhuang   +3 more
wiley   +1 more source

Operative Efficiency and Short‐Term Outcomes of Robotic Transabdominal Preperitoneal Inguinal Hernia Repair: A Prospective Single‐Surgeon Cohort Study

ANZ Journal of Surgery, Volume 96, Issue 9, Page 2640-2646, September 2026.
ABSTRACT Background Robotic transabdominal preperitoneal inguinal hernia repair (R‐TAPP IHR) is a promising minimally invasive tool for inguinal hernias. This study aimed to evaluate short‐term postoperative outcomes following R‐TAPP IHR from a high‐volume robotic surgeon who has passed the initial robotic learning curve.
Yusef Hafez, Aleksandar Strkalj, Joseph Do Woong Choi, Mark Bukofzer, Stephen Pillinger, Christos Apostolou   +5 more
wiley   +1 more source

Temporal Trends in Intracavernosal Injection Therapy and Penile Prosthesis Implantation in the Era of Phosphodiesterase‐5 Inhibitors for Erectile Dysfunction in Australia

ANZ Journal of Surgery, Volume 96, Issue 9, Page 2498-2505, September 2026.
ABSTRACT Introduction Phosphodiesterase‐5 inhibitors (PDE5‐Is) transformed erectile dysfunction (ED) management as first‐line therapy; nonetheless, many patients require second‐ and third‐line options due to inadequate response, side effects, or contraindications.
Nicholas Gillman, Eric Chung
wiley   +1 more source